Genetron Health receives US FDA breakthrough device designation for its blood-based NGS test for early detection of hepatocellular carcinoma
The US FDA’s Center for Devices and Radiological Health. (Credit: The U.S. Food and Drug Administration)
NS Medical Devices is using cookies
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X